Xiangqi Li

604 total citations
33 papers, 405 citations indexed

About

Xiangqi Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiangqi Li has authored 33 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Xiangqi Li's work include Hippo pathway signaling and YAP/TAZ (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Immunotherapy and Immune Responses (3 papers). Xiangqi Li is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Immunotherapy and Immune Responses (3 papers). Xiangqi Li collaborates with scholars based in China, United Kingdom and United States. Xiangqi Li's co-authors include Changran Wei, Ying Wang, Kai Li, Guodong Li, Liyan Sun, Yunfeng Li, Jimei Zhang, Yijia Cao, Yaping Liu and Qiu‐Xu Teng and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Pharmacology and Energies.

In The Last Decade

Xiangqi Li

31 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangqi Li China 11 217 116 112 62 51 33 405
Sarah Libring United States 10 247 1.1× 133 1.1× 70 0.6× 104 1.7× 56 1.1× 17 442
Honglong Wei China 11 188 0.9× 77 0.7× 133 1.2× 104 1.7× 22 0.4× 12 422
Lucia Minoli Italy 12 223 1.0× 135 1.2× 67 0.6× 78 1.3× 102 2.0× 31 455
Iratxe Zuazo-Gaztelu United States 5 173 0.8× 82 0.7× 99 0.9× 62 1.0× 55 1.1× 6 321
Man Wu China 10 233 1.1× 145 1.3× 84 0.8× 55 0.9× 70 1.4× 16 438
Yujie Hu China 11 205 0.9× 139 1.2× 47 0.4× 67 1.1× 64 1.3× 31 470
Saima Usman United Kingdom 6 170 0.8× 108 0.9× 40 0.4× 82 1.3× 38 0.7× 9 343
Jae Woo Jung South Korea 14 255 1.2× 97 0.8× 72 0.6× 84 1.4× 50 1.0× 31 453

Countries citing papers authored by Xiangqi Li

Since Specialization
Citations

This map shows the geographic impact of Xiangqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangqi Li more than expected).

Fields of papers citing papers by Xiangqi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangqi Li. The network helps show where Xiangqi Li may publish in the future.

Co-authorship network of co-authors of Xiangqi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangqi Li. A scholar is included among the top collaborators of Xiangqi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangqi Li. Xiangqi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lianyong, Fengying Wu, Chenxi Li, et al.. (2025). Delineating unique MASH-endothelial cells in metabolic dysfunction-associated steatotic liver disease using single-cell lensing. Digestive and Liver Disease. 57(10). 1974–1984.
2.
Li, Xiangqi, et al.. (2025). The Role of The Xihuang Pill in Inhibiting Triple-Negative Breast Cancer Through Immunogenic Cell Death. Breast Cancer Targets and Therapy. Volume 17. 793–803.
3.
Li, Wenjing, et al.. (2024). The therapeutic role of γδT cells in TNBC. Frontiers in Immunology. 15. 1420107–1420107. 5 indexed citations
4.
Hu, Huiwen, et al.. (2023). The relationship between the Hippo signaling pathway and bone metastasis of breast cancer. Frontiers in Oncology. 13. 1188310–1188310. 5 indexed citations
5.
Hu, Huiwen, et al.. (2023). Role of Caveolae family-related proteins in the development of breast cancer. Frontiers in Molecular Biosciences. 10. 1242426–1242426. 6 indexed citations
6.
Li, Xiangqi, et al.. (2023). FPDsim: A Structural Simulator For Power Grid Analysis Of Flat Panel Display. 1–6. 1 indexed citations
7.
Liu, Lianyong, Fengying Wu, Xiaoying Zhang, & Xiangqi Li. (2023). PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinomaby Inducing EVA1A Expression. Current Cancer Drug Targets. 24(2). 192–203. 1 indexed citations
8.
Wei, Changran, et al.. (2022). The Signaling Pathways Associated With Breast Cancer Bone Metastasis. Frontiers in Oncology. 12. 855609–855609. 33 indexed citations
9.
10.
Wei, Changran, et al.. (2022). The Relationship Between Microbial Community and Breast Cancer. Frontiers in Cellular and Infection Microbiology. 12. 849022–849022. 21 indexed citations
11.
Wei, Changran, et al.. (2021). Association between γδ T cells and clinicopathological features of breast cancer. International Immunopharmacology. 103. 108457–108457. 5 indexed citations
12.
Wei, Changran, et al.. (2021). The potential role and status of IL-17 family cytokines in breast cancer. International Immunopharmacology. 95. 107544–107544. 33 indexed citations
13.
14.
Wei, Changran & Xiangqi Li. (2020). The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor. Frontiers in Pharmacology. 11. 557429–557429. 67 indexed citations
15.
Li, Xiangqi, Yunfeng Li, Li Liu, et al.. (2020). Latin Hypercube Sampling Method for Location Selection of Multi-Infeed HVDC System Terminal. Energies. 13(7). 1646–1646. 9 indexed citations
16.
Liu, Xiaofei, et al.. (2019). Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis. BMC Complementary and Alternative Medicine. 19(1). 48–48. 10 indexed citations
17.
Li, Xiangqi, Kai Li, Guodong Li, & Liyan Sun. (2018). PTEN and SHIP: Impact on lymphatic metastasis in breast cancer. Journal of Cancer Research and Therapeutics. 14(12). 937–937. 15 indexed citations
18.
Wei, Changran, Ying Wang, & Xiangqi Li. (2018). The role of Hippo signal pathway in breast cancer metastasis. OncoTargets and Therapy. Volume 11. 2185–2193. 63 indexed citations
19.
Li, Xiangqi. (2012). Effects of Shugan jianpi formula on lymphangiogenesis and expressions of Ang-2 and nm23 in breast cancer tissue. 1 indexed citations
20.
Li, Xiangqi, et al.. (2012). Expression of survivin and VEGF-C in breast cancer tissue and its relation to lymphatic metastasis.. PubMed. 33(2). 178–82. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Libring Breakdown of academic impact, for papers by Honglong Wei Breakdown of academic impact, for papers by Lucia Minoli Breakdown of academic impact, for papers by Iratxe Zuazo-Gaztelu Breakdown of academic impact, for papers by Man Wu Breakdown of academic impact, for papers by Yujie Hu Breakdown of academic impact, for papers by Saima Usman Breakdown of academic impact, for papers by Jae Woo Jung
Rankless by CCL
2026